Traf7, a MyoD1 transcriptional target, regulates nuclear factor-κB activity during myogenesis.

TitleTraf7, a MyoD1 transcriptional target, regulates nuclear factor-κB activity during myogenesis.
Publication TypeJournal Article
Year of Publication2010
AuthorsTsikitis M, Acosta-Alvear D, Blais A, Campos EI, Lane WS, Sánchez I, Dynlacht BD
JournalEMBO Rep
Volume11
Issue12
Pagination969-76
Date Published2010 Dec
ISSN1469-3178
KeywordsAnimals, Cell Cycle, Cell Differentiation, Cyclin D1, Gene Expression Regulation, I-kappa B Kinase, Intracellular Signaling Peptides and Proteins, Mice, Muscle Development, Myoblasts, MyoD Protein, NF-kappa B, Phosphorylation, Protein Binding, Retinoblastoma Protein, Transcription, Genetic, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Ubiquitin, Ubiquitination
Abstract

We have identified the E3 ligase Traf7 as a direct MyoD1 target and show that cell cycle exit-an early event in muscle differentiation-is linked to decreased Traf7 expression. Depletion of Traf7 accelerates myogenesis, in part through downregulation of nuclear factor-κB (NF-κB) activity. We used a proteomic screen to identify NEMO, the NF-κB essential modulator, as a Traf7-interacting protein. Finally, we show that ubiquitylation of NF-κB essential modulator is regulated exclusively by Traf7 activity in myoblasts. Our results suggest a new mechanism by which MyoD1 function is coupled to NF-κB activity through Traf7, regulating the balance between cell cycle progression and differentiation during myogenesis.

DOI10.1038/embor.2010.154
Alternate JournalEMBO Rep.
PubMed ID20948544
PubMed Central IDPMC2999857
Grant List1 R21 CA125734-01 / CA / NCI NIH HHS / United States
2R01 GM067132 / GM / NIGMS NIH HHS / United States
K22 CA115998-03 / CA / NCI NIH HHS / United States